FUJIFILM Toyama Chemical Co., Ltd.
Year | Month | History |
---|---|---|
2018 | Oct. | FUJIFILM RI Pharma merged TOYAMA CHEMICAL. Company name changed to FUJIFILM Toyama Chemical Co., Ltd. |
2019 | Jan. | Launch of medication verification system "PROOFIT 1D" |
2019 | Feb. | Launch of ORAVI® Mucoadhesive Tablets 50mg for Oropharyngeal Candidiasis in Japan |
2019 | Dec. | Completion of manufacturing facility for liposome formulations in Toyama Second Factory |
2021 | Feb. | Approval of PEMETREXED INTRAVENOUS INFUSION 100mg/500mg "TOWA" |
2021 | Apr. | Transfer of rights to IOPROMIDE Injection and IOPROMIDE Injection Syringe to Bayer Yakuhin, Ltd. in Japan |
2021 | Jun. | Approval of LUTATHERA® Ingection and LYSAKARE® Injection |
2021 | Jul. | Succession of the constant-temperature transportation device business to TOHO PHARMACEUTICAL CO., LTD. |
2021 | Sep. | Approval of Raiatt MIBG-I 131 Injection |
2021 | Nov. | Transfer of marketing rights for ORAVI® Mucoadhesive Tablets 50mg to Hisamitsu Pharmaceutical |
2022 | Mar. | Succession of the radiopharmaceutical business to PDRadiopharma Inc. |
TOYAMA CHEMICAL Co., Ltd.
Year | History |
---|---|
1936 | Toyama Chemical Co., Ltd., established around the business of Toyama Chemical Research Laboratory |
1961 | Head office relocated from Toyama to Nihonbashi, Tokyo |
Listed on the second section of the Tokyo Stock Exchange | |
1970 | General Research Laboratory completed |
1971 | Factory for the manufacture of injectable products completed |
1972 | Listed on the first section of the Tokyo Stock Exchange |
First phase of pharmaceutical factory completed | |
1975 | No. 2 Research Laboratory completed |
Second phase of pharmaceutical factory completed | |
1978 | Head office relocated from Nihonbashi to Shinjuku, Tokyo |
1979 | Approval of PENTCILLIN injection and intramuscular |
1980 | No. 3 Research Laboratory completed |
1981 | Approval of ABOVIS capsules Toyama Second Factory established |
1982 | Approval of BAXO capsules |
1985 | No. 5 Research Laboratory completed |
1986 | Approval of BAXO ointment |
1987 | Approval of TOMIRON tablet |
1988 | Approval of BAXO suppositories |
1989 | No. 1 Research Laboratory completed |
1990 | Approval of OZEX tablet |
Approval of TOMIRON fine granules | |
1998 | Pharmaceutical factory and distribution wing completed |
1999 | LUPRAC tablet introduced in Japan |
2002 | HALOSPOR intravenous introduced in Japan |
Agreed on a strategic capital and business alliance with Taisho Pharmaceutical Co., Ltd. | |
Approval of PASIL intravenous drip | |
Taisho Toyama Pharmaceutical Co., Ltd. established | |
Approval of PENTCILLIN intravenous bag | |
2006 | Approval of OZEX ophthalmic solution |
No. 6 Research Laboratory completed | |
2007 | Approval of GENINAX tablet |
2008 | Agreed on a strategic capital and business alliance between FUJIFILM Holdings Corporation, Taisho Pharmaceutical Co., Ltd. and Toyama Chemical Co., Ltd. |
Delisted on the first section of the Tokyo Stock Exchange | |
Approval of ZOSYN intravenous | |
2009 | Approval of OZEX fine granules |
2012 | No. 7 Research Laboratory completed |
Approval of KOLBET tablet | |
2013 | Factory for the manufacture of injectable products completed |
2014 | Factory for the manufacture of injectable bag products completed |
Approval of AVIGAN tablet | |
Approval of ZOSYN intravenous bag | |
2018 | Transfer of rights to KOLBET tablet to Eisai Co., Ltd. in Japan |
Toyama Chemical Co., Ltd. became 100% subsidiary of FUJIFILM Corporation |